Neogen Financial Statements From 2010 to 2026

NEOG Stock  USD 9.19  0.18  1.92%   
Neogen's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Neogen's valuation are provided below:
Neogen does not presently have any fundamental ratios for analysis.
Check Neogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neogen's main balance sheet or income statement drivers, such as , as well as many indicators such as . Neogen financial statements analysis is a perfect complement when working with Neogen Valuation or Volatility modules.
Check out the analysis of Neogen Correlation against competitors.
For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.

Neogen Company Return On Equity Analysis

Neogen's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Neogen Return On Equity

    
  -0.25  
Most of Neogen's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neogen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Neogen has a Return On Equity of -0.2525. This is 98.95% lower than that of the Health Care Equipment & Supplies sector and 96.22% lower than that of the Health Care industry. The return on equity for all United States stocks is 18.55% lower than that of the firm.

Neogen Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Neogen's current stock value. Our valuation model uses many indicators to compare Neogen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neogen competition to find correlations between indicators driving Neogen's intrinsic value. More Info.
Neogen is regarded fifth in return on equity category among its peers. It is regarded second in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Neogen by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

About Neogen Financial Statements

Neogen stakeholders use historical fundamental indicators, such as Neogen's revenue or net income, to determine how well the company is positioned to perform in the future. Although Neogen investors may analyze each financial statement separately, they are all interrelated. For example, changes in Neogen's assets and liabilities are reflected in the revenues and expenses on Neogen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Neogen. Please read more on our technical analysis and fundamental analysis pages.
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. Neogen Cp operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 2108 people.

Currently Active Assets on Macroaxis

When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports:
Check out the analysis of Neogen Correlation against competitors.
For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.